Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2025-12-25 @ 4:13 PM
Study NCT ID:
NCT00048659
Status:
TERMINATED
Last Update Posted:
2012-06-07
First Post:
2002-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D011471', 'term': 'Prostatic Neoplasms'}], 'ancestors': [{'id': 'D005834', 'term': 'Genital Neoplasms, Male'}, {'id': 'D014565', 'term': 'Urogenital Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D005832', 'term': 'Genital Diseases, Male'}, {'id': 'D000091662', 'term': 'Genital Diseases'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}, {'id': 'D011469', 'term': 'Prostatic Diseases'}, {'id': 'D052801', 'term': 'Male Urogenital Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C449179', 'term': 'N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}}, 'statusModule': {'overallStatus': 'TERMINATED', 'statusVerifiedDate': '2012-06', 'completionDateStruct': {'date': '2004-06', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2012-06-06', 'studyFirstSubmitDate': '2002-11-04', 'studyFirstSubmitQcDate': '2002-11-05', 'lastUpdatePostDateStruct': {'date': '2012-06-07', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2002-11-06', 'type': 'ESTIMATED'}}, 'conditionsModule': {'keywords': ['Androgen-independent prostate cancer'], 'conditions': ['Hormone-Refractory Prostate Cancer', 'Prostatic Neoplasms']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to determine if patients who take YM598 in addition to mitoxantrone and prednisone (standard therapy) experience improvement in the pain associated with prostate cancer metastases in the bone.'}, 'eligibilityModule': {'sex': 'MALE', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False}, 'identificationModule': {'nctId': 'NCT00048659', 'briefTitle': 'YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy', 'organization': {'class': 'INDUSTRY', 'fullName': 'Astellas Pharma Inc'}, 'orgStudyIdInfo': {'id': '598-CL-008'}}, 'armsInterventionsModule': {'interventions': [{'name': 'YM598', 'type': 'DRUG'}]}, 'contactsLocationsModule': {'locations': [{'city': 'Anchorage', 'state': 'Alaska', 'country': 'United States', 'facility': 'Alaska Clinical Research Center, LLC', 'geoPoint': {'lat': 61.21806, 'lon': -149.90028}}, {'city': 'San Bernardino', 'state': 'California', 'country': 'United States', 'facility': 'San Bernardino Urological Associates', 'geoPoint': {'lat': 34.10834, 'lon': -117.28977}}, {'city': 'Torrance', 'state': 'California', 'country': 'United States', 'facility': 'Western Clinical Research, Inc.', 'geoPoint': {'lat': 33.83585, 'lon': -118.34063}}, {'city': 'Gainesville', 'state': 'Florida', 'country': 'United States', 'facility': 'Shands Hospital', 'geoPoint': {'lat': 29.65163, 'lon': -82.32483}}, {'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'Sylvester Comprehensive Cancer Center', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Georgia Urology,PA Research Institute', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'city': 'Chicago', 'state': 'Illinois', 'country': 'United States', 'facility': 'University of Chicago, Section of Hematology/Oncology', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'city': 'Chicago', 'state': 'Illinois', 'country': 'United States', 'facility': 'University of Illinois, Department of Urology', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'city': 'South Bend', 'state': 'Indiana', 'country': 'United States', 'facility': 'Michiana Hematology/Oncology', 'geoPoint': {'lat': 41.68338, 'lon': -86.25001}}, {'city': 'Gretna', 'state': 'Louisiana', 'country': 'United States', 'facility': 'The Urologic Institute of New Orleans', 'geoPoint': {'lat': 29.91465, 'lon': -90.05396}}, {'city': 'Detroit', 'state': 'Michigan', 'country': 'United States', 'facility': 'Henry Ford Hospital', 'geoPoint': {'lat': 42.33143, 'lon': -83.04575}}, {'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Washington University School of Medicine', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'city': 'Memphis', 'state': 'Tennessee', 'country': 'United States', 'facility': 'Memphis Cancer Center', 'geoPoint': {'lat': 35.14953, 'lon': -90.04898}}, {'city': 'Seattle', 'state': 'Washington', 'country': 'United States', 'facility': 'Virginia Mason Medical Center', 'geoPoint': {'lat': 47.60621, 'lon': -122.33207}}, {'city': 'Canberra', 'country': 'Australia', 'facility': 'Department of Medical Oncology, The Canberra Hospital', 'geoPoint': {'lat': -35.28346, 'lon': 149.12807}}, {'city': 'Concord', 'country': 'Australia', 'facility': 'Department of Medical Oncology, Concord Hospital Medical Centre', 'geoPoint': {'lat': -33.84722, 'lon': 151.10381}}, {'city': 'Herston', 'country': 'Australia', 'facility': 'Division of Oncology Ward, Royal Brisbane Hospital', 'geoPoint': {'lat': -27.44453, 'lon': 153.01852}}, {'city': 'St Leonards', 'country': 'Australia', 'facility': 'Department of Clinical Oncology, Royal North Shore Hospital', 'geoPoint': {'lat': -33.82344, 'lon': 151.19836}}, {'city': 'Sydney', 'country': 'Australia', 'facility': 'Cancer Care Centre, St. George Hospital', 'geoPoint': {'lat': -33.86785, 'lon': 151.20732}}, {'city': 'Waratah', 'country': 'Australia', 'facility': 'Department of Medical Oncology, Newcastle Mater Hospital', 'geoPoint': {'lat': -32.90667, 'lon': 151.72647}}, {'city': 'Wollongong', 'country': 'Australia', 'facility': 'Southern Medical Day Care Centre', 'geoPoint': {'lat': -34.424, 'lon': 150.89345}}, {'city': 'Woodville', 'country': 'Australia', 'facility': 'Queen Elizabeth Hospital, Clinical Hematology & Oncology', 'geoPoint': {'lat': -34.877, 'lon': 138.54291}}, {'city': 'Brussels', 'country': 'Belgium', 'facility': "Cliniques Universitaires St-Luc, Service d'Urologie", 'geoPoint': {'lat': 50.85045, 'lon': 4.34878}}, {'city': 'Charleroi', 'country': 'Belgium', 'facility': "Centre Hospitalier Notre Dame et Reine Fabiola, Service d'oncologie", 'geoPoint': {'lat': 50.41136, 'lon': 4.44448}}, {'city': 'Angers', 'country': 'France', 'facility': 'Centre Paul Papin', 'geoPoint': {'lat': 47.47156, 'lon': -0.55202}}, {'city': 'Créteil', 'country': 'France', 'facility': "Service d'Urologie, Hôpital Henri Mondor", 'geoPoint': {'lat': 48.79266, 'lon': 2.46569}}, {'city': 'Lyon', 'country': 'France', 'facility': "Pavillon V, Service d'Urologie et de transplatation, Hôpital Edouard Herriot", 'geoPoint': {'lat': 45.74906, 'lon': 4.84789}}, {'city': 'Paris', 'country': 'France', 'facility': "Service d' Urologie CHU, Hopital Bichat", 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}, {'city': 'Berlin', 'country': 'Germany', 'facility': 'Krankenhause am Urban, Urologie Dieffenfachstr', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'city': 'Essen', 'country': 'Germany', 'facility': 'Dept Urology University of Essen', 'geoPoint': {'lat': 51.45657, 'lon': 7.01228}}, {'city': 'Hanover', 'country': 'Germany', 'facility': 'Urologische Klinik der MHH', 'geoPoint': {'lat': 52.37052, 'lon': 9.73322}}, {'city': 'Mannheim', 'country': 'Germany', 'facility': 'Klinikum Mannheim Urology', 'geoPoint': {'lat': 49.4891, 'lon': 8.46694}}, {'city': 'Dublin', 'country': 'Ireland', 'facility': 'Mater Misericordiae Hospital', 'geoPoint': {'lat': 53.33306, 'lon': -6.24889}}, {'city': 'Utrecht', 'country': 'Netherlands', 'facility': 'Universitair Medisch Centrum Utrecht, Dienst Medische Oncologie', 'geoPoint': {'lat': 52.09083, 'lon': 5.12222}}, {'city': 'Krakow', 'country': 'Poland', 'facility': 'Kilinika Chemioterapii, Centrum Onkologii Instytut im M sklodowskiej Curie', 'geoPoint': {'lat': 50.06143, 'lon': 19.93658}}, {'city': 'Krakow', 'country': 'Poland', 'facility': 'Oddzial Chemioterapii', 'geoPoint': {'lat': 50.06143, 'lon': 19.93658}}, {'city': 'Lodz', 'country': 'Poland', 'facility': 'Klinika Chemioterapii AM', 'geoPoint': {'lat': 51.77058, 'lon': 19.47395}}, {'city': 'Opole', 'country': 'Poland', 'facility': 'Samodzielny Publiczny Zaklad Opieki zdrowotnej, Wojewodzki Osrodek Onkologii', 'geoPoint': {'lat': 50.67119, 'lon': 17.92604}}, {'city': 'Tarnów', 'country': 'Poland', 'facility': 'Szpital Wojewodzki im Sw Lukasza SP ZOZ Tarnow', 'geoPoint': {'lat': 50.01381, 'lon': 20.98698}}, {'city': 'Warsaw', 'country': 'Poland', 'facility': 'Klinika Nowotworow Ukladu', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'city': 'Warsaw', 'country': 'Poland', 'facility': 'Szpital CSK WAMl, Klinika Okologii', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'city': 'Barcelona', 'country': 'Spain', 'facility': 'Hospital Clinic i Provincial, Servicio de Oncologia', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'city': 'Barcelona', 'country': 'Spain', 'facility': "Hospital General Vall d'Hebron, Servicio de Oncología", 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'city': 'Getafe (Madrid)', 'country': 'Spain', 'facility': 'Hospital Universitario de Getafe, Servicio de Urologia, Crta', 'geoPoint': {'lat': 40.30571, 'lon': -3.73295}}, {'city': 'Madrid', 'country': 'Spain', 'facility': 'Hospital Universitario Príncipe de Asturias, Servicio de Urología', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'city': 'Valencia', 'country': 'Spain', 'facility': 'Instituto Valenciano de Oncologia, Servicio de Oncologia', 'geoPoint': {'lat': 39.47391, 'lon': -0.37966}}, {'city': 'Devon', 'country': 'United Kingdom', 'facility': 'Department of Urological Research, Derriford Hospital'}, {'city': 'London', 'country': 'United Kingdom', 'facility': "Clinical Research Centre, St George's Hospital, Urology Division", 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'city': 'London', 'country': 'United Kingdom', 'facility': "Department of Urology, St Bartholomew's Hospital", 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'city': 'London', 'country': 'United Kingdom', 'facility': 'Imperial College School of Medicine, Dept Cancer Medicine', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}, {'city': 'Surrey', 'country': 'United Kingdom', 'facility': 'Department of Urology, East Surrey Hospital'}, {'city': 'Surrey', 'country': 'United Kingdom', 'facility': 'Royal Surrey County Hospital'}, {'city': 'West Sussex', 'country': 'United Kingdom', 'facility': "St Richard's Hospital"}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Astellas Pharma Inc', 'class': 'INDUSTRY'}, 'collaborators': [{'name': 'Astellas Pharma US, Inc.', 'class': 'INDUSTRY'}]}}}